Literature DB >> 885041

Cerebellar role in smooth pursuit movement.

P Nemet, S Ron.   

Abstract

It is generally believed that pursuit eye movements are unaffected by cerebellar cortical atrophy or cerebellectomy. The present study was performed on patients who underwent partial vermis and hemisphere ablations as a result of severe cranial injury or cerebellar tumors. Eye movements were measured by DC electro-oculography. A clear disparity of the slow phase of the optokinetic nystagmus was observed. When eye movements were contralateral to the ablated side the slow phase of optokinetic nystagmus was statistically slower than drum or visual field velocity. It is suggested that the cerebellum network is involved in the mechanisms of the smooth pursuit movement.

Entities:  

Mesh:

Year:  1977        PMID: 885041     DOI: 10.1007/bf01569295

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  7 in total

1.  Editorial: How the oculomotor system repairs itself.

Authors:  D A Robinson
Journal:  Invest Ophthalmol       Date:  1975-06

2.  The cerebellum involvement in the generation of saccades.

Authors:  S Ron; P Nemet
Journal:  Doc Ophthalmol       Date:  1977-04-29       Impact factor: 2.379

3.  Eye tracking of self-moved targets: the role of efference.

Authors:  M J Steinbach
Journal:  J Exp Psychol       Date:  1969-11

4.  Eye tracking of observer-generated target movements.

Authors:  M J Steinbach; R Held
Journal:  Science       Date:  1968-07-12       Impact factor: 47.728

5.  Oculomotor defects in cerebellectomized monkeys.

Authors:  G Westheimer; S M Blair
Journal:  Invest Ophthalmol       Date:  1973-08

6.  Saccades and the quick phase of nystagmus.

Authors:  S Ron; D A Robinson; A A Skavenski
Journal:  Vision Res       Date:  1972-12       Impact factor: 1.886

7.  Changes in saccadic eye movements produced by cerebellar cortical lesions.

Authors:  J C Aschoff; B Cohen
Journal:  Exp Neurol       Date:  1971-08       Impact factor: 5.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.